UBS Group’s ETRACS 2x Leveraged US Dividend Factor TR ETN SCDL Stock Holding History

UBS Group’s Portfolio SCDL Stock Details SCDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.68M	Buy	145,900 +2,400	+2%	+$125K	﹤0.01%	3739
2026 Q1	$7.07M	Sell	143,500 -1,700	-1%	-$81.1K	﹤0.01%	3708
2025 Q4	$5.75M	Buy	+145,200	New	+$5.59M	﹤0.01%	3890
2025 Q3	–	Sell	-200	Closed	-$7.33K	–	10854
2025 Q2	$7.33K	Buy	+200	New	+$7.04K	﹤0.01%	9026
2024 Q3	–	Sell	-73	Closed	-$2.57K	–	9993
2024 Q2	$2.57K	Hold	73	–	–	﹤0.01%	8332
2024 Q1	$2.76K	Sell	73 -85	-54%	-$2.95K	﹤0.01%	7835
2023 Q4	$5.33K	Buy	+158	New	+$4.7K	﹤0.01%	7793
2023 Q1	–	Sell	-246	Closed	-$8.29K	–	10277
2022 Q4	$8.29K	Buy	246 +43	+21%	+$1.39K	﹤0.01%	8790
2022 Q3	$5K	Buy	203 +137	+208%	+$4.32K	﹤0.01%	9220
2022 Q2	$2K	Buy	+66	New	+$2.28K	﹤0.01%	9607

UBS Group's SCDL Position: Q2 2026 in Review

UBS Group increased its ETRACS 2x Leveraged US Dividend Factor TR ETN (SCDL) stake by 1.7% in Q2 2026, buying an estimated $125K and bringing the position to 145,900 shares worth $7.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3739.

UBS Group first reported a position in SCDL in Q2 2022 and has held it in 10 quarters since. 1 fund tracked by Wall St. Rank holds SCDL as of Q2 2026.

UBS Group held 145,900 shares of ETRACS 2x Leveraged US Dividend Factor TR ETN worth $7.68M as of Q2 2026.
UBS Group bought 2,400 ETRACS 2x Leveraged US Dividend Factor TR ETN shares in Q2 2026, an estimated $125K.
ETRACS 2x Leveraged US Dividend Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3739 holding.
UBS Group first reported a position in ETRACS 2x Leveraged US Dividend Factor TR ETN in Q2 2022 and has held it in 10 quarters since.
1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged US Dividend Factor TR ETN as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.